Clinical Trials Logo
  1. Home
  2. Visual Impairment
  3. NCT02896738
  4. Details
NCT02896738 Clinical Trial

MRI Screening for Auditory Pathway Malformations in Visually Impaired Children

Visual Impairment Clinical Trial

— DIMAVE  

Official title:
MRI Screening for Auditory Pathway Malformations in Visually Impaired Children

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02896738
Other study ID # LBU_2015_6
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 2015
Est. completion date April 12, 2022

Study information
Verified date April 2022
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This pilot study aims to assess the interest to add an auditory pathway morphological analysis during the MRI exploration of visual pathway in visually impaired children.

Recruitment information / eligibility
Status Completed
Enrollment 126
Est. completion date April 12, 2022
Est. primary completion date March 2, 2022
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - age < 18 years old - visual impairment - MRI scheduled to explore their visual impairment - parents' informed consent for participation in the study Exclusion Criteria: - tumoral origin for the visual impairment - no health insurance coverage

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Fondation Ophtalmologique Adolphe de Rothschild Paris

Sponsors (1)
Lead Sponsor Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary number of patients with Auditory Pathway Malformation baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT05619432 - Re:Garde Program - Training and Maintaining Visual Perception in Older Adults N/A
Completed NCT03670303 - Trial of an Educational Intervention to Promote Spectacle Use Among Secondary School Children in Islamabad, Pakistan N/A
Completed NCT01822717 - Nonvisual Foot Inspection for People With Visual Imapirment N/A
Completed NCT03865134 - Evaluation of Visual - Motor Development in Children With Retinopathy of Prematurity
Active, not recruiting NCT04198350 - Pancreatic Islet Transplantation to the Anterior Chamber of the Eye N/A
Recruiting NCT05220449 - Re-Orchestration of Interregional Oscillatory Activity to Promote Visual Recovery N/A
Completed NCT04190147 - Eye and Growth in Adolescents Born Moderate-to-late Preterm
Completed NCT05135195 - A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training N/A
Recruiting NCT05199363 - Pediatric Patient Experience on a Diagnostic Path N/A
Active, not recruiting NCT03767803 - Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Recruiting NCT03571217 - Shanghai Beixinjing Diabetic Eyes Study
Not yet recruiting NCT03726606 - A Comparison of the Visual Performance of Trifocal Versus Extended Depth of Focus Intraocular Lenses N/A
Completed NCT02259088 - A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients Phase 3
Completed NCT06197607 - Effect of Hand Exercises on Hand Grip Strength and Manual Ability in Children With Visual Impairment N/A
Withdrawn NCT04579653 - Pupillometry and Locus Coeruleus Activation (PuLCA) N/A
Recruiting NCT05844982 - Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy Phase 3
Recruiting NCT02258113 - Measuring of Neuro-visual Functionality With Ocusweep N/A
Completed NCT02607384 - The Baltimore Reading and Eye Disease Study N/A
Completed NCT00901186 - Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema Phase 2